12:00 AM
Apr 29, 2013
 |  BC Week In Review  |  Company News  |  Other News

Hikma Pharmaceuticals drug delivery news

Hikma completed a review of strategic options for its global injectables business and decided to retain and continue to invest in the...

Read the full 89 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >